INVESTING
in medtech, focusing on cardio and GI with first-in-human trials complete.
EXPLORE OUR PORTFOLIO →
Our Unorthodoxy
Structure: With the resources of a VC but just a single LP, we make investing decisions quickly and focus on long-term success, not short-term cashouts.
Investments: Seed and Series A with later investments also possible. Check sizes range from $1 million to $5 million with follow-on investments common.
Expertise: Unlike most VCs, we're not bankers. With strong backgrounds in engineering and marketing, our staff helps portfolio companies with PR and manufacturing, as well as go-to-market modeling for those pre-revenue.
Unorthodox support: We offer space at our Austin headquarters to our companies free of charge. Use our 30,000-square-foot warehouse to store trade show booths, products and sales collateral. Opening an American office? Base your first employees here while finding a permanent home.
FEATURED MEDTECH COMPANY
A completely different kind of treatment
Among our portfolio companies is Israel's Vibrant Gastro, which developed a vibrating capsule to treat the chronic constipation suffered by one in five adults. Traditional laxative treatments ruin their lives, causing unpredictable diarrhea. Vibrant Gastro's FDA-cleared drug-free device restores the colon's natural rhythm, giving you more bowel movements and, most importantly, predictable ones at regular times of day so you can once again live your life.
MEET VIBRANT GASTRO →FEATURED CONSTRUCTION TECH COMPANY
Safer, more efficient construction sites
Our portfolio company KEWAZO, based in Berlin, provided a much-needed change for construction scaffolding, which continues to be done largely manually with more than 80% of projects relying on human labor. The company's LIFTBOT robot, which is battery-powered and entirely wireless, moves materials up and down scaffolding twice as efficiently as humans and significantly reduces the risk of accidents and falling objects.
MEET KEWAZO →
BLOG
Contrarian to the core
Not surprisingly, we believe more people should think like us. Read on for our opinions about business and why so many people make needless mistakes. (Spoiler alert: It's typically greed and groupthink.)
Who’s on Board? (Or Saving CEOs from Themselves)
Allowing CEOs on the boards of their companies is not good for business and almost always leads to turmoil, as the OpenAI upheaval proved.
Holy Cow (Or When Quality Is Out of Control)
Recent recalls of generic drugs illustrate the inevitable problems when you manufacture anything without strict oversight, especially in a country like India.
MEDIA
We're loud and proud
We have a lot to say, and people have a lot to say about us.
OUR APPROACH
We invest in early-stage startups all around the world, often helping overseas companies open their first American offices. Click below to tell us about your work.
Contact Us →